Chemed (CHE)
(Real Time Quote from BATS)
$569.53 USD
-48.42 (-7.84%)
Updated Apr 25, 2024 02:56 PM ET
4-Sell of 5 4
D Value A Growth A Momentum B VGM
Industry / Sector Report
Industry : Medical - Outpatient and Home Healthcare
Zacks Industry Rank
Bottom 39% (154 out of 251)Zacks Sector Rank
Top 19% (3 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.33 | 1.68 | 9.99 |
Current Quarter Estimate | 5.78 | 0.69 | 60.00 |
Year Ago Quarter Estimate | 4.71 | 1.31 | 52.54 |
Next Quarter Estimate | 5.85 | 0.72 | 61.00 |
Next Year Estimate | 25.55 | 5.93 | 270.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 15.81 | 11.60 | 17.08 |
Next Year | 8.68 | 17.20 | 8.00 |
Last 5 Years | 14.10 | 6.50 | 8.10 |
Next 5 Years | 11.30 | 11.30 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 28.31 | 13.83 |
Price/Book (MRQ) | 8.40 | 2.28 |
Price/Cash Flow (MRFY) | 25.16 | 12.17 |
Dividend Yield | 0.26% | 0.00% |
Net Profit Margin (TTM) | 12.36% | -88.48% |
Return on Equity (TTM) | 31.69% | -50.54% |
Debt to Equity (MRQ) | NA | 0.29 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.